Centogene N.V announced that Oved Amitay will be stepping down as Chief Business Officer and leaving the Company effective May 31, 2020. He will be succeeded by Sun Kim, current Chief Strategy and IR Officer, who will assume Mr. Amitay’s responsibilities until a permanent CBO has been appointed. Mr. Amitay will continue his work for rare diseases patients in the non-profit sector, where he will serve as Chief Executive Officer of a patient advocacy organization. Prior to joining CENTOGENE, M...